NotaQuenSAN (sanPharma GmbH)


Welcome to the PulseAid listing for the NotaQuenSAN drug offered from sanPharma GmbH. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: sanPharma GmbH
NON-PROPRIETARY NAME: PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM and PENICILLIUM GLABRUM
SUBSTANCE NAME: PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM; PENICILLIUM GLABRUM
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: NASAL
DOSAGE FORM: SPRAY
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2017-01-04
END MARKETING DATE: 0000-00-00


NotaQuenSAN HUMAN OTC DRUG Details:

Item DescriptionNotaQuenSAN from sanPharma GmbH
LABELER NAME: sanPharma GmbH
DEA SCHEDULE:
ACTIVE STRENGTH: 4; 4([hp_X]/10mL; [hp_X]/10mL)
START MARKETING DATE: 2017-01-04
END MARKETING DATE: 0000-00-00
PRODUCT ID: 64232-046_db0783ae-ff6b-4028-b902-80a47ff99844
PRODUCT NDC: 64232-046
APPLICATION NUMBER:

Other PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM; PENICILLIUM GLABRUM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
BioResource Inc.Notatum-Quentans Nasal 4X
sanPharma GmbHNotaQuenSAN
Sanum-Kehlbeck GmbH & Co. KGPleo Nota-Quent
Syntrion GmbHSyInfect
USPharmaCoNotatum-Quentans